Optimisation of pressurized liquid extraction using a multivariate chemometric approach for the determination of anticancer drugs in sludge by ultra high performance liquid chromatography–tandem mass spectrometry by Seira, Jordan et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
To link to this article: DOI:10.1016/j.chroma.2013.01.114 
 
http://dx.doi.org/10.1016/j.chroma.2013.01.114 
 
 
 
 
 
 
This is an author-deposited version published in: http://oatao.univ-toulouse.fr/  
Eprints ID: 9948 
To cite this version:  
 
Seira, Jordan and Claparols, Catherine and Joannis-Cassan, Claire and 
Albasi, Claire and Montréjaud-Vignoles, Mireille and Sablayrolles, 
Caroline Optimisation of pressurized liquid extraction using a multivariate 
chemometric approach for the determination of anticancer drugs in sludge 
by ultra high performance liquid chromatography–tandem mass 
spectrometry. (2013) Journal of Chromatography A, vol. 1283 . pp. 27-38. 
ISSN 0021-9673 
Open Archive Toulouse Archive Ouverte (OATAO)  
OATAO is an open access repository that collects the work of Toulouse researchers and 
makes it freely available over the web where possible.  
 
Any correspondence concerning this service should be sent to the repository 
administrator: staff-oatao@listes-diff.inp-toulouse.fr 
 
Optimization of pressurized  liquid  extraction using  a  multivariate
chemometric  approach  for  the determination of  anticancer  drugs in
sludge  by  ultra  high  performance liquid  chromatography–tandem
mass  spectrometry
Jordan  Seira a,b,∗,  Catherine  Claparols c,d, Claire  Joannis-Cassan a, Claire  Albasi a,
Mireille  Montréjaud-Vignolesb, Caroline  Sablayrollesb,∗∗
a Université de Toulouse, INP-ENSIACET, CNRS, Laboratoire de  Génie Chimique, 4  allée Emile Monso, F-31432 Toulouse Cedex 4,  France
b Université de Toulouse, INP-ENSIACET, INRA, Laboratoire de Chimie Agro-Industrielle, 4 allée Emile Monso,  F-31432 Toulouse Cedex 4,  France
c CNRS, Laboratoire de  Chimie de Coordination, 205 route de Narbonne, BP 44099, F-31077 Toulouse Cedex 4,  France
d Université de Toulouse, UPS, Service Commun de  Spectrométrie de  Masse, 118 route de  Narbonne, F-31077 Toulouse Cedex 4, France
Keywords:
Anticancer drugs
Sludge
Experimental design
Pressurized  liquid extraction
Ultra  high performance liquid
chromatography
Tandem mass spectrometry
a  b  s t  r  a c t
The  present  paper  describes  an  analytical  method  for  the  determination  of  2 widely  administered  anti-
cancer  drugs,  ifosfamide  and  cyclophosphamide,  contained  in sewage  sludge.  The  method  relies on the
extraction  from  the  solid  matrix  by  pressurized  liquid  extraction,  sample  purification  by  solid-phase
extraction  and  analysis  by  ultra  high  performance  liquid chromatography  coupled  with  tandem  mass
spectrometry.  The  different  parameters  affecting  the  extraction  efficiency  were optimized  using  an
experimental  design.  Solvent  nature  was the  most decisive  factor for  the  extraction  but interactions
between  some  parameters  also  appeared  very  influent.  The method  was  applied to seven  different  types
of  sludge  for  validation.  The performances  of  the  analytical  method  displayed  high variability  between
sludges  with  limits  of  detection  spanning  more  than  one  order of  magnitude  and  confirming  the  rele-
vance  of  multi-sample  validation.  Matrix  effect  has  been determined  as the  most  limiting  analytical  step
for  quantification  with  different  extent  depending  on analyte  and  sludge nature.  For each analyte,  the
use  of  deuterated  standard  spiked  at the  very  beginning  ensured  the  complete  compensation  of  losses
regardless  of  the  sample  nature. The suitability  of  the  method  between  freshly  spiked  and  aged  sam-
ples  has  also  been  verified.  The optimized  method  was  applied  to different  sludge  samples  to  determine
the  environmental  levels  of  anticancer  drugs. The compounds  were  detected  in some  samples  reaching
42.5  mg/kgDM in  ifosfamide  for the  most  contaminated  sample.
1. Introduction
Pharmaceutical residues in  the environment and their possible
biological or side effects on non-target organisms are an  emerg-
ing research in environmental sciences [1]. The interest about their
occurrence, their fate and their toxicity in the environment really
took off at the end of 1990s and the number of  publications has
been constantly increasing since then [2].
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After administration, large fractions of  pharmaceuticals are
not completely assimilated or metabolized in  the body and then
excreted as  parent compounds or metabolites via urine and feces
[3]. These  compounds are collected and mixed in wastewaters,
in which their concentrations can reach some mg/L [4]. Pharma-
ceutical compounds suffer from partial removal during activated
sludge treatment, the most common wastewater treatment plant
(WWTP). Consequently, WWTP effluents are recognized as  the
primary spreading source of  pharmaceutical pollution in the envi-
ronment.
During activated sludge treatment, trace pollutants can mainly
be affected by three mechanisms: volatilization, biodegradation or
sorption onto sludge, depending on both compound and sludge
physico-chemical properties. Therefore, volatilization is  usually
neglected for pharmaceuticals because of low Henry’s constant
[5]. While biodegradation has sometimes the signification of com-
plete elimination, sorption onto sludge can be considered as a
         
displacement of the pollution from the aqueous to the solid phase.
Monitoring trace pollutants in solid part could be of  crucial impor-
tance because of (1) possible influence toward bioavailability (i.e.
biodegradation) to microorganisms and (2) stabilized-sludge land-
fill applications which can introduce sludge-born trace pollutants
in the environment, increasing potential exposure risks. Conse-
quently, investigating occurrence of trace compounds in  biosolids
could be a key factor for (1) upgrading WWTPs and trace pollut-
ants removal and (2) the establishment of new regulations which
are only focused on heavy metals, polychlorobiphenyls (PCBs) and
polycyclic aromatic hydrocarbons (PAHs) for trace pollutants in
sludge-amended soil applications.
Among  the broad spectrum of available pharmaceutical prod-
ucts, there is still  one class that paid little attention in  spite of
an environmentally devastating potential: the anticancer drugs.
Including antineoplastic and endocrine-therapy drugs, these com-
pounds are designed to  prevent or disrupt cellular proliferation
in cancer treatment schemes [6]. Unlike some other therapeutic
classes, anticancer drugs exhibit very different physico-chemical
properties. To name a  few, some examples are log Kow ranging
from – 2.46 to 6.3 and pKa ranging from 1.45 to  9.8 [2]. Most of
the anticancer drugs possess a  strong carcinogenic, mutagenic and
teratogenic potential and are thought as one of the most hazardous
contaminants in water cycle [7]. Due to their mode of action, it
is assumed that almost all eukaryotic organisms are vulnerable
to genetic damages at very  low concentrations [8]. As highlighted
by the literature, their consumption is  increasing and trends,
including type of consumed drugs and practices of  consumption,
are diversifying [6].
The  monitoring of anticancer drugs in the environment has
encountered a tremendous interest for the last 3  years. Comprehen-
sive overviews including analytical methods for their analysis [9],
data about their environmental occurrence and fate [2]  and assess-
ment of environmental exposure [6] have been published under
this period. These states-of-art revealed that environmental occur-
rence of anticancer drugs in  water samples are few documented but
data about their occurrence in solid samples are definitively scarce.
Although analytical development for their determination in liquid
samples is still of concern but fairly common, there is a great need
of accurate analytical method focused on their detection in  more
challenging matrices such as solid part of sludge.
Performing extraction of  trace pollutants from solid matrices
is not easy to handle. A  variety of procedures has been defined
in the literature and can be divided in two distinct groups: clas-
sical and recent extraction techniques [10]. Classical techniques
include mechanical stirring, Soxhlet and Soxtec, and ultrasound
extraction (USE), the  later has been used one time for the extrac-
tion of anticancer drugs in sludge samples [11]. Most of  them are
labor-intensive, time-consuming and require large amounts of  sol-
vents. Their application to solids is noticeably dropped and replaced
with more time-saving and eco-friendly processes. Recent extrac-
tion techniques include micro-wave assisted extraction (MWE) and
pressurized liquid (including hot water) extraction (PLE) among
many examples. A comprehensive overview about the extrac-
tion of trace pollutants from sludge according different extraction
techniques is available [10]. Due to the increasing number of  pub-
lished papers, PLE and its derivatives appear as  the most promising
technique for efficient extraction [12,13]. Up to now, only  one appli-
cation of PLE has been reported for the extraction of  anticancer
drugs in sludge samples [14].
Depending on the extractive conditions applied, the recovery of
variable amounts of co-interfering compounds during PLE is possi-
ble [15]. To address this well-known drawback, a  clean-up extract
is often required. In most of cases, this step is performed by solid-
phase extraction (SPE). With the emergence of mixed-mode SPE
implying polar, non-polar and ionic interactions with the sorbent,
selective  purification is allowed. Thus, mixed-mode SPE could be
promising for recovering analytes with different physico-chemical
properties and enhancing method specificity. Mixtures containing
anticancer drugs are usually separated by  liquid chromatography
[2,9]. The trace level occurrence of  these drugs in  environmental
samples justifies the use of sophisticated systems such as  mass
spectrometry (MS) detection. Thus, ultra high pressure liquid
chromatography–tandem mass spectrometry (UHPLC–MS/MS)
appears as  the most powerful and adequate tool for fast  separation
and very selective and sensitive detection in  complex matrices [10].
In light  of  these concerns, one of  our objectives was to  develop
and validate an  analytical method for determining the occurrence
of anticancer drugs in the solid part of  sludge. The drugs of  interest
are the alkylating cytotoxics cyclophosphamide (CP) and ifosfamide
(IFO) and the antiestrogen hormonally active tamoxifen (TAM).
Some of  their relevant physico-chemical properties are given in
Fig. 1. Among all the anticancer drugs, the investigation of  their fate
has recently been defined as  preferential due to  their consumption
data, their behavior in WWTP and related predicted environmental
concentrations (PEC) in  the literature [6]. The method is based on
the extraction from the solid matrix using semi-exhaustive PLE,
extract clean-up using tandem Oasis MAX/MCX selective SPE and
analysis by UHPLC–MS/MS. To highlight the influence of  experi-
mental conditions, optimization of  PLE parameters was realized
according to an  experimental design. The method was validated for
seven sludge samples representative of the French WWTPs profile.
Some efforts have been carried out  to identify which analytical
step was detrimental in the determination of  anticancer drugs.
The use  of  deuterated standards has also been applied to  check for
possible complete compensation of  losses through the analytical
procedure. To  our knowledge, this is the first time that  anticancer
drugs have been investigated in sludge originated from French
WWTPs.
2. Experimental
2.1. Analytical standards and chemicals
Analytical standards cyclophosphamide monohydrate (CP),
ifosfamide (IFO), tamoxifen (TAM) were purchased from
Sigma–Aldrich (Saint-Quentin de Fallavier, France) and deuterated
cyclophosphamide-d4 (CP-d4), ifosfamide-d4 (IFO-d4), tamoxifen-
d5 (TAM-d5)  were purchased from Toronto Research Chemicals
(North York, Ontario, Canada) as  chemical powders.
Methanol (MeOH), acetonitrile (ACN) and acetone were HPLC
grade and purchased from Scharlau (Spain). Hydrochloric acid
(HCl) 37% and formic acid (HCOOH) 99% were purchased from
VWR Prolabo (Fontenay-sous-Bois, France). Ammonium hydroxide
(NH4OH) 35% was purchased from Fischer Chemical (Loughbor-
ough, Leicestershire, UK). Ammonium acetate (NH4CH3COO) 98%
was purchased from Merck (Damstadt, Germany). Na2EDTA was
purchased from ICN BioMedicals (Aurora, OH, USA). The ultra pure
water used for laboratory purposes as well as  LC  mobile phase was
produced from demineralized water by a  MilliPore system (Mol-
sheim, France).
Stock  solution (∼1000 mg/L) of each individual standard was
prepared every 4  months by  dissolving the appropriate amount in
MeOH. Before any experiment, working solutions (i.e. dilution of
the stock solution) were prepared in  MeOH to  the required con-
centration. Two distinct mixtures of standards CP (∼2 mg/L), IFO
(∼2 mg/L), TAM (∼0.5 mg/L) and deuterated CP-d4 (2 mg/L), IFO-d4
(2 mg/L), TAM-d5 (0.3 mg/L) were prepared in this way. For con-
venience, the terms MIX Standards and MIX Deuterated will now
be used throughout this document. To  minimize degradation of
standards, stock and working standards solutions were wrapped
in aluminum and stored at −20 ◦C after preparation.
Fig. 1.  MRM chromatogram of  spiked FS IMBR sludge sample.
2.2. Analytical procedure
Determining  the anticancer compounds in sludge was carried
out according to a procedure of  several determinative steps includ-
ing sample pre-treatment, extraction, purification and analysis
(Fig. 2).
2.2.1.  Sample collection and pre-treatment
Sludge samples used in  this study were originated from different
full-scale or pilot-scale WWTPs in Midi-Pyrenees and Languedoc-
Roussillon regions (France). Samples were collected during grab
sampling campaigns between March 2009  and November 2011.
For each sampling campaign, a  sufficient amount of sludge (>5 L)
was retrieved and transferred to polypropylene cans. Samples
were originated from three conventional activated sludge (CAS),
one full-scale (FS) internal membrane bioreactor (IMBR), two
pilot-scale  (PS)  IMBR and external MBR (EMBR) and one thickened
primary–secondary (TPS) sludge. Details about WWTPs and some
related features such as sludge acronyms used throughout this doc-
ument are given in Table 1.  All the above mentioned samples were
characterized and distinguished according to  volatile suspended
solid (VSS) measurement. VSS was obtained after calcination of
total suspended solid (TSS) at 525 ◦C during 2  h in a furnace. TSS
measurement was determined by filtration of a  known volume of
sludge according to AFNOR regulation NF EN 872 [16].
Briefly after transport to  the laboratory, each sludge sample was
allowed to settle and supernatant was discarded. The remaining
sludge was then centrifuged to  ensure a  complete separation
between particular and aqueous phases. A great amount of  set-
tled sludge (1 L for each run) was centrifuged during 20 min at
5000 × g with a Megafuge 40 R centrifuge from Fischer Scientific
(Illkirch, France) operated at sludge temperature. All  the pellets
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Fig. 2. Methodology applied for the determination of  anticancer drugs in sludge.
were combined and frozen at −20 ◦C.  Iced sludge pellets were
then freeze-dried at obscurity and −60 ◦C under 0.045 bar vacuum
(Christ Alpha 1-2 LD, Bioblock Scientific, Illkirch, France), ground
to thin particles (<0.5 mm) using a  mortar and pestle and stored at
−20 ◦C prior to use.
2.2.2.  Sample extraction
A  Dionex accelerated solvent extraction (ASE) 200 device
(Dionex, Sunnyvale, USA), which is  the trade name for PLE, was
used for the extraction of anticancer drugs from sludge.
At  the bottom of  each extraction cell, one glass-fiber filter
(Dionex, Voisins-le-Bretonneux, France) was placed to  ensure the
filtration of semi-aqueous extracts. A thin sand layer (Fisher Sci-
entific, Loughborough, UK) was then applied for pre-filtration. The
dried biosolid sample was weighted (0.35 g), spiked with 100 mL
of MIX Deuterated and mixed thoroughly with sand as  dispersing
agent to prevent aggregation during extraction process and reduce
clumping and channeling. The ratio between sample and sand
weight  was about 0.04. The mixture was then placed in  the extrac-
tion cell and covered with an  additional layer of  sand. The cell was
not completely filled with sand. A  dead space about 0.25 cm was
left to  keep threads and sealing surfaces safe. To  allow more repre-
sentative adsorption of  spiked analytes in  sludge, built cells were
left at room temperature for a  minimum of 24  h before extraction.
The extraction solvent and operating conditions were optimized
according to a  multivariate experimental design shortly detailed in
this paper. MeOH/ultra pure water mixture (65/35, v/v) was used
as extraction solvent. The operating conditions were as  follows:
extraction pressure, 85  bar; extraction temperature, 100 ◦C; no pre-
heat period; static extraction time, 9  min; number of static cycles,
4; flush volume, 60% of  the cell; purge time, 120 s. This procedure
led to a  final extract volume of  15 ± 2 mL for all the samples.
2.2.3.  Extract clean-up
Extracts  were transferred to rocket-shaped bottles (200 mL)
and evaporated to around 5  mL with a TurboVap II concentration
Table 1
Features  of sludges used in this study.
Sludge Scale Person equivalent Organic load Technology pH VSS (%)
FS VLCAS Full 300 000 Very low CAS 8.3 79
FS  LCAS Full 2000 Low CAS – 83
FS  MCAS Full 800 000 Medium CAS 7.25 91
FS  IMBR Full 9000 Very low Internal MBR 7.55 75
LS  EMBR Lab (20  L)  – Lowa External MBR 7.7 84
LS  IMBR Lab (15 L) – Lowb Internal MBR 7.5 89
TPS  Full >30 000 – Thickener 7.8 71
CAS: conventional activated sludge; MBR: membrane bioreactor; VSS:  volatile suspended solids; FS VLCAS: FullScale VeryLowCAS; FS  LCAS: FullScale LowCAS; FS MCAS:
FullScale MediumCAS; FS IMBR: FullScale InternalMBR; LS  EMBR: LabScale ExternalMBR; LS IMBR: LasScale InternalMBR; TPS: thickened primary secondary.
a Semi-synthetic influent using same wastewater as FS  MCAS.
b Fed with the same wastewater as FS  MCAS.
workstation (Caliper Life Sciences, Hopkinton, USA) operating
at 30 ◦C under a nitrogen N2 pressure of 1  bar. The evaporation
lasted 2 h. The clean-up procedure has already been submitted for
aqueous samples [17] and was adapted to our  purposes. Clean-up
has been carried out using selective SPE tandem approach Oasis
MAX/MCX cartridges from Waters (Saint-Quentin-en-Yvelines,
France).  The solvent mixtures used for SPE were prepared
every week.
The  5-mL extract was dissolved in 150 mL of ultra pure water.
ASE vial collection was also rinsed with 50  mL (5× 10  mL) of ultra
pure water and transferred to the mixture for a  final volume about
200 mL. Sample pH was adjusted to 12 with NH4OH 35% and mixed
thoroughly with EDTA 5%  (0.01% in  the sample, w/w). A MAX car-
tridge (6 cm3,  150 mg) was initially conditioned with 4  mL of  MeOH,
4 mL of acetone and 4 mL of  NH4OH 0.5%. A 70-mL SPE propyl-
ene sample reservoir from Macherey-Nagel (Hoerdt, France) was
stacked on the cartridge before loading the sample at a  flow rate of
1 mL/min. A wash solution of  4 mL NH4OH 0.5% in MeOH/ultra pure
water mixture (5/95, v/v) was applied and followed by  the elution of
targeted analytes with 4 mL of MeOH and 6  mL of  acetone collected
in a same fraction. The volume of  the fraction was concentrated
down to 2 mL and dissolved in  70 mL of ultra pure water corrected
at pH 2  with HCl 37%. A MCX cartridge (6 cm3,  150  mg) was then
conditioned with 4 mL of  MeOH, 4  mL of acetone and 4  mL of  ultra
pure water at pH 2. The sample was loaded (1 mL/min) on a 70-
mL SPE propylene adaptator. The cartridge was rinsed with 4 mL
of MeOH/ultra pure water (pH 2) mixture (5/95, v/v). The excess
water present in  the cartridge was removed with a strong vac-
uum during 15 min  and the sorbent was completely dried under
N2 stream during 20  min. The elution of  neutrals IFO and CP was
performed with 4  mL of MeOH followed by the elution of basic TAM
with 6  mL of NH4OH 2% in acetone in two distinct fractions. Details
of SPE procedure, retention mechanisms and interest of  cartridges
combination are given elsewhere [17]. The volume of the extracts
was reduced down to 1  mL and transferred to  vials from Agilent
Technologies (Massy, France). The extracts were then evaporated
to dryness and redissolved in  1  mL of  (A)/(B) mobile phase mixture
(75/25, v/v) (see Table 2  for composition) using a  vortex apparatus
from Fischer Scientific (Illkirch, France). A filtration on a  Spartan
RC 0.45 mm syringe filter from VWR (Fontenay-sous-Bois, France)
was performed for each extract. The extracts were finally stored at
4 ◦C and obscurity during a  maximum duration of 7 days prior to
analysis.
2.2.4. UHPLC–MS/MS analysis
LC  separation was carried out using an Ultimate 3000 UHPLC
System from Dionex (France). The column used for separation was
an ACQUITY UPLC® BEH C18 (50 mm × 2.1 mm) with a 1.7 mm par-
ticle size diameter (Waters, Saint-Quentin en Yvelines, France). All
details about LC conditions such as injection volume, flow rate, auto
sampler and column temperatures, elution gradient are  given in
Table 2.
Table 2
Liquid  chromatography conditions.
Parameter Applied condition
Injection volume 10 mL
Flow  rate 400  mL/min
Auto  sampler temperature 15 ◦C
Column oven temperature 25 ◦C
Mobile phase Eluent A Eluent B
Ultra pure water/ACN (90/10, v/v)
NH4CH3COO 1 mM
HCOOH 0.3%
Pure  ACN
LC  gradient %  Eluent A % Eluent B
Time (min)
0 100  0
0.5 100 0
2 78  22
3.5 77  23
4 0  100
6 0  100
8 100 0
10 100 0
Detection was achieved with an Applied Biosystems Sciex
QTRAP® hybrid linear ion-trap triple quadrupole mass spectrom-
eter (Foster City, USA) equipped with a Turbolon-Spray Interface.
The instrument was operated in ElectroSpray (ESI) positive (+)  in
Multiple Reaction Monitoring (MRM) mode (dwell time, 80 ms).
The operating parameters were: capillary voltage, 5000 V; source
temperature, 450 ◦C; gas N2; curtain gas, 20; Ion source gas  1,  20;
ion source gas 2,  70. Before any experiment, a  soft cleaning of the
cone entrance was performed to maintain top instrumental per-
formance. For each compound, cone voltage and collision energies
of the main transitions were optimized. MS and MRM conditions
are summarized in  Table 3. For  MS spectra and chromatogram
acquisition and exploitation, Analyst 1.6.1 software from Applied
Biosystems Sciex (Foster City, USA) was used.
A minimum of 3  identification points were applied to  unam-
biguously identify the analytes in environmental samples. Each
compound was characterized according to (1) its retention time
tR in  comparison with the corresponding standard for each batch
process with a  tolerance of  ±5%, (2) the monitoring of  two  transi-
tions per analyte and (3) its presence in one of the 2  SPE extracts. A
typical chromatogram of targeted analytes in real sample is given
in Fig. 1.
For  quantification, MRM transitions were used. Six-point cali-
bration curves were generated. From working solutions, identical
amounts of deuterated analytes were added to  the calibration stan-
dards, which contained related analytes in concentration spanning
about 2 orders of magnitude. The calibration standards were evap-
orated to dryness, redissolved in 1  mL of  (A)/(B) mobile phase
mixture (75/25, v/v) and filtered at 0.45 mm. Calibration curves
Table 3
MS  and MRM conditions used to  identify and quantify pharmaceuticals.
Pharmaceutical Detection Transitions (m/z) DPa (V) EPb (V) CEc (V) CXPd (V)
IFO Positive 261.1  > 92.0 (Q) 65 10  30  12
261.1  > 153.8 (q) 65  10  24  12
CP Positive 261.1  > 139.8 (Q) 65 10  27  12
261.1  > 105.9 (q) 65 10  22  12
TAM Positive 372.4  > 72.0 (Q) 65 10  40  15
372.4  > 128.9 (q) 65 10  35  15
Q: quantification transition; q: confirmatory transition.
a Declustering potential.
b Entrance potential.
c Collision energy.
d Collision cell exit potential.
were performed at the beginning of  each batch process. Curves
were built by calculating the ratios between the peak area of  each
analyte and the peak area of corresponding deuterated standard
using weighted 1/x model for linear regression. Along the sequence,
quality control (QC) samples were also analyzed to confirm their
validity. QC samples were a  high- and low-concentration level of
the curves (1 order of  magnitude). No significant (<12%) deviation
has been observed. As sludge extracts may content many inter-
fering compounds, blank samples (mobile phase mixture without
analytes) were included every 5 injections. No cross-contamination
has been observed. At  the end of each sequence, chromatographic
column was washed thoroughly with acidified water (pH 3) and
pure ACN.
Instrumental detection limits (IDL) and instrumental quantifica-
tion limits (IQL) were determined by serial dilution of  each standard
down to  2 pg injected. The IDL and IQL were set as a  signal-to-noise
(S/N) ratio of 3 and 10  of the chromatographic response respec-
tively.
2.3. Method performances
The  performances of the analytical procedure were evaluated for
each analyte through the estimation of  method efficiency, repeat-
ability and reproducibility, sensitivity and matrix effect. Estimation
of the linearity was also considered as  part of  the validation.
2.3.1.  Validation procedure
To  demonstrate the robustness of the analytical procedure, the
seven sludge samples defined in  Table 1  were submitted to the
validation process. For each freeze-dried biosolid, 4  samples were
spiked with 100 mL  of both MIX Standards and Deuterated and 1
sample was spiked with 100 mL of MIX Deuterated for native ana-
lyte concentration. All the samples were then submitted to the
previously described protocol. This experimental set-up allows for
the determination of  the efficiency of  the entire procedure (i.e.
method efficiency MEff) and not for each analytical step. The deter-
mination of the MEff was calculated following Eq. (1):
method efficiency MEff (%) =
Qpreextract − Qback
Qspike
×  100 (1)
where  Qpreextract is the amount in the extract after complete pro-
cedure (ng), Qback is  the amount present in the native sample
(background quantity) (ng) and Qspike is the quantity of  the spike
(ng).
For three freeze-dried sludges (FS LCAS, FS MCAS, FS  IMBR),
MEff was also determined over a  range of 4 concentrations. For
each sludge candidate, 4 samples were spiked with 100 mL of MIX
Deuterated and different volumes of MIX Standards (10, 50, 100,
200 mL) to achieve concentrations in the samples of  60, 300, 600,
1200 mg/kg of dry matter (DM) and then submitted to the entire
protocol. Measured analyte concentrations were plotted as a  func-
tion of their related spiked concentrations and the corresponding
slope was determined (Slopeplotted). Four-concentration MEff was
determined for each analyte according to Eq. (2):
four-concentration method efficiency MEff (%) =
Slopeplotted
Slopecalibration
× 100 (2)
where  Slopeplotted is  the slope previously defined, Slopecalibration is
the slope of the calibration curve. In both experiments, absolute
and relative MEff were calculated. For  relative MEff, all the values
were corrected relative to  the deuterated analogues.
Repeatability (intra-day precision) was expressed as  the relative
standard deviation (RSD, %) obtained from the MEff experiment at
a  single concentration and extracted, purified and analyzed in the
same batch. Reproducibility (inter-day precision) was defined and
conducted in the same conditions but on different batches and was
determined only for three freeze-dried sludges (FS LCAS, FS MCAS,
FS IMBR).
The sensitivity of the analytical method was determined accord-
ing to the definitions of  method detection limits (MDL) and method
quantification limits (MQL). MDL  and MQL were calculated using
Eq. (3):
method limits ML (mg/kgDM) =
IL ×  Vextract
MEffabs × m
(3)
where  IL  is the considered instrumental limit (mg/L), Vextract is the
volume of the final extract (=1 mL), MEffabs is the absolute method
efficiency calculated for a single concentration (0 <  MEffabs <  1), m is
the dried sample weight (=0.35 g).
2.3.2. Analytical limitation
To  evaluate the performances of each analytical step, freeze-
dried samples and subsequent extracts were spiked at different
steps of  the procedure with 100 mL of  both MIX Standards and
Deuterated. The experimental scheme was inspired from the lit-
erature [18] and conducted in triplicate for FS MCAS and FS IMBR.
Spikes were applied:
(a)  Before freeze-drying on rehydrated freeze-dried samples to
assess  true MEff;
(b) Before extraction to evaluate the combined recovery of extrac-
tion,  purification and analysis (MEff defined in Section 2.3.1);
(c) Before purification on Oasis MAX to evaluate the recovery of
both  purification and analysis;
(d) Before purification on Oasis MCX to evaluate the recovery of
second  purification and analysis;
(e) Before analysis to  evaluate the recovery of the analysis.
Absolute and relative recoveries were determined in the same
way as for MEff estimation. The following Eq. (4)  was used for
calculation:
recovery (%) =
Qstep −  Qback
Qspike
× 100 (4)
where  Qstep is  the amount in the final extract after spike to  the cor-
responding analytical step (ng). For relative recovery, all the values
were corrected relative to the deuterated analogues.
The spiking procedure applied in (e) also allows for the deter-
mination of  matrix effect (ME), according to Eq.  (5):
matrix  effect ME (%) =
(
Apostextract −  Aback
Aspike
−  1
)
× 100  (5)
where  Apostextract is the area in  the extract spiked just before the
analysis, Aback is the area in the extract of  native unspiked sam-
ple (background area) and Aspike is  the area of the corresponding
spike. Absolute ME calculation was based on the area of  analyte
without correction while relative ME was calculated related to the
deuterated analogue area.
The  accurate determination of  the recoveries for each analyt-
ical step was possible. The efficiency of  each detailed step was
determined according to Eq. (6):
analytical step n efficiency (%) =
Rn
Rn+1
×  100 (6)
where  R is  the absolute or  relative recovery (%) at a  given spik-
ing step, n is  a value ranging from 1 to 4  and describing a  specific
analytical step. Thus, the corresponding steps are:
(n = 1) pretreatment (i.e. freeze-drying) by comparing experiments
(a)  and (b)
(n  = 2) extraction by comparing experiments (b)  and (c)
(n = 3) purification I (i.e. Oasis MAX) by  comparing experiments (c)
and (d)
(n  = 4) purification II  (i.e. Oasis MCX) by  comparing experiments
(d)  and (e)
3. Results and discussion
3.1.  Optimization of PLE
3.1.1.  Selection of extraction solvent
The solvent must be able to solubilize the targeted analytes from
the matrix with few interfering compounds as far  as  possible. Since
the analytes vary in physico-chemical properties, the choice of sol-
vent mixtures was crucial but also  limited. Our strategy for selecting
mixtures relies on (1) solvents previously applied with success in
the literature and (2) close polarity matching between analytes and
solvent mixtures. Different pure and binary solvents were tested.
Pure solvents were acetone, MeOH, ACN, water (pH 7) and binary
mixtures were acetone/ACN (1:1), MeOH/ACN (1:1), acetone/water
(1:1), MeOH/water (1:1) and ACN/water (1:1). As no detectable
concentration of  targeted anticancer drugs was measured, FS LCAS
sludge was selected, spiked with 100 mL of  both MIXs and sub-
mitted to the whole analytical process. All the experiments were
performed in duplicate. Initial PLE conditions were applied from
the literature: extraction pressure, 138  bar; extraction tempera-
ture, 100 ◦C; no pre-heat period; static cycle extraction time, 5  min;
number of static cycles, 3;  flush volume, 60% of  the cell; purge time,
120 s [14]. The solvent mixture efficiency was investigated by com-
paring the mean areas of  targeted analytes for each tested condition
(data not shown). Areas of  deuterated analogues were also com-
pared. In the same time, extraction cells filled with dispersing agent
were spiked and extracted in the same conditions to investigate
the thermal degradation of  analytes. No significant losses occurred
under chosen parameters, thus confirming the stability.
For  the tested solvents, all targeted analytes were recovered in
different amounts. Extracts exhibiting different aspects were also
obtained. Pure and mixed organic solvents led to  highly colored
and clear extracts while water led  to brown and very turbid ones.
Semi-organic mixtures gave intermediate profiles. Turbid aqueous
samples were responsible for the clogging of  the cartridge during
the purification. Consequently, water (pH 7) was not selected as
extraction solvent in  our experimental scheme. Higher areas were
obtained for IFO and CP using MeOH/water (1:1) and for TAM using
pure MeOH. No discrepancies were observed for deuterated ana-
logues areas. ACN and derived mixtures gave the worst results for
each compound. The lower efficiency of ACN for extracting pharma-
ceuticals from solid samples has already been reported [13,18,19].
Unsurprisingly, water mixtures were efficient to extract polar ana-
lytes IFO and CP while pure organic solvents were efficient to
extract apolar TAM. As TAM analysis was more sensitive than for
IFO and CP, MeOH/water as  extraction solvent was found to  be a
good compromise. From the literature and our findings, the supe-
rior capability of MeOH/water mixture to extract pharmaceuticals
from solid samples has been found [13,18–23].
3.1.2. Optimization using experimental design
The number of parameters affecting PLE is very high so the one
variable at a time (OVAT) strategy was not  to  consider here. Finding
the best operating conditions for maximizing recoveries with few
experiments was achieved using a central composite design (CCD).
According to the literature, the parameters of interest were the sol-
vent (MeOH/water) ratio (variable A), the extraction temperature
(variable  B), the extraction pressure (variable C), the static cycle
duration (variable D) and the number of  cycles (variable E) [24].
The CCD consisted in  a  fractional factorial design including the five
variables at two  levels (25−1), each augmented by ten star points
and 6  center points. The total number of extractions was 32. The
low and high levels (domain boundaries) for each parameter were
common PLE values determined from the literature [10,24]. These
values were 10–90% (MeOH/water ratio), 70–110 ◦C (temperature),
70–130 bar (pressure), 4–16 min  (cycle duration) and 1–5 (num-
ber of cycles). The complete definition of  the experimental design
applied is  given in  Supplementary Content 1. FS LCAS sludge was
chosen for optimization as  no targeted analytes have been detected.
To evaluate the efficiency of  extraction, 100 mL  of MIX Standards
were spiked prior to  extraction and 100 mL of MIX Deuterated were
spiked into the corresponding extract.
Supplementary material related to  this article found, in the
online version, at http://dx.doi.org/10.1016/j.chroma.2013.01.114.
The recoveries obtained for each analyte and experiment are
given in  Supplementary Content 2.  Some yields were superior to
100% which could be attributed to  method errors, sludge sample
inhomogeneity [25] or signal ion enhancement during analysis. In
the  defined experimental domain, TAM displayed strong variability
with values ranging from 0 to 205%. Moreover, the variability was
remarkably high for the 6 center points (experiments 27–32). It
suggested that TAM extraction was affected by an  unconsidered
parameter or any other unknown process. A  simple experiment
was conducted by washing thoroughly with organic solvent the
laboratory vessel and analyzing the solvent. Quantifiable amounts
of TAM have been measured, confirming adsorption phenomena.
Determination of TAM was therefore not possible. For the other
analytes, the variability at the 6  center points has been determined
(Supplementary Content 2). IFO exhibited less variability than CP
with a  relative standard deviation (RSD) of 6% versus 13%.
Supplementary  material related to  this article found, in the
online version, at http://dx.doi.org/10.1016/j.chroma.2013.01.114.
The Minitab® software was used for the statistical study. Owing
to the CCD, the coefficients of  a  second order polynomial model
describing the effects of  the 5 variables on IFO and CP recovery have
been estimated. The two models adequately represented the data
as lack-of-fit p-values were superior to 0.05 (0.21 for IFO and 0.26
for CP). The correlation between predicted and observed recoveries
was up to  99% for IFO and 98% for CP.
In order to see which variables (i.e. parameters) were the most
influent on the response, standardized Pareto charts were con-
structed and are given in Fig. 3. Trends between IFO and CP were
rather similar. In both cases, the solvent ratio was probably the most
determining factor for extraction efficiency. However, its influence
was difficult to assess, as this parameter was implied in  several
significant interactions sometimes of opposite trends. Indeed, it
appeared that some interactions between parameters, such as A * D
and A *  E for example, were strongly influent. It means that varia-
tions in  extraction recovery were not strictly assigned to a  single
parameter but could also be  due to synergistic effects of two  or
more variables. These results justify the use of  experimental design
rather than OVAT strategy.
Our  objective was to determine the best values of  the five param-
eters that allow a  recovery of  around 100% with a 5% tolerance. Due
to the second order of  the models, an infinite combination of  the
factors allows to reach this goal. So  response surface methodology
was used to  determine the area where the criterion is fulfilled. The
values of  the five parameters were chosen in these areas, taking
into account the following experimental considerations.
First, aqueous or highly aqueous extracts were not recom-
mended in our experimental scheme due to possible cartridge
clogging. Moreover, the more polar the solvent mixture, the less
selective extraction is  [15]. Consequently, semi-organic content
         
Fig. 3. Standardized Pareto chart  highlighting the effect of  PLE parameters in applied experimental design for IFO (up) and CP (down). The vertical straight line is the limit
of significance.
was preferential (middle of domain). Then, the application of  high
temperature in PLE decreases the viscosity of  the solvent, thus
allowing its better penetration into sample matrix and increasing
its capacity to solubilize the analytes [20]. Faster extraction rates
are also expected with high temperatures [15]. Nevertheless, high
temperature could also lead to loss in method selectivity due to  the
extraction of more co-extractable compounds [20]. Relatively high
temperature was thus preferential (upper part of domain). Next,
pressure seemed to be the less significant parameter, which is  a
common finding in  the literature for PLE [13,25,26]. Its role  is  to
maintain  the solvent in the liquid state at extraction temperature.
Low pressure was sufficient (lower part of domain). Finally, the dura-
tion and number of cycles were determined simultaneously. Long
cycle time could lead to a better diffusion of  analytes but the multi-
plication of short cycle could be favorable to recovery [20]. Indeed,
the introduction of fresh solvent at each cycle could allow new
equilibrium between analytes and solvent, which could be inter-
esting for strongly entrapped analytes. Consequently, low cycle
duration (lower part of the domain) and many cycles (upper part
of the domain) were preferential. Taking account of  these reasons,
surface responses were plotted and displayed in  Supplementary
Contents 3 and 4. The chosen experimental conditions were the
following: MeOH/water 65/35 (v/v), extraction temperature 100 ◦C,
extraction pressure 85 bar,  static cycle duration 9  min and 4 cycles.
Supplementary material related to this article found, in  the
online version, at http://dx.doi.org/10.1016/j.chroma.2013.01.114.
3.2. Extract clean-up
Extract  clean-up was required to  concentrate the analytes
and to remove the interfering components. As sludge was
expected to contain much more interferents than wastewater
samples, high sorbent weights (150, 500 and 1000 mg) were
applied. Briefly, three types of sorbents were selected: reversed
phase, hydrophilic–lipophilic balance (HLB) and mixed-mode
anionic-cationic exchange. FS LCAS sludge PLE extracts were gen-
erated and spiked prior to purification. Reversed phase sorbent
yielded very low recoveries for IFO and CP  and were rejected.
HLB yielded better recoveries but the major part  of interfer-
ing compounds were concentrated in the final extract, which
could introduce analytical troubles (i.e. strong matrix effect) with
more complex sludge samples. Therefore, HLB sorbents were
rejected. In our previous study [17], mixed-mode anionic- and
cationic-exchange SPE has proven value in the selective recover of
targeted analytes in sludge aqueous samples with relatively low
matrix effect. This procedure has been retained. As the sorbent
weight for purification was two  times and a half higher, the con-
ditioning, washing and eluting volumes were multiplied by two.
Lightly colored and clear extracts were obtained for most of  the
samples. Purification procedure was then considered satisfactory.
3.3.  Performances of the analytical method
As no CRM was available for validation, in-house material was
used. In-house material was freeze-dried sludge spiked with a
known amount of  targeted analytes. Seven different types of sludge
were studied to demonstrate the complete suitability of  the proce-
dure.
The linearity of  the internal calibration curves was satisfac-
tory (R2 > 0.995) for IFO and CP over the tested concentrations
(1–500 mg/L) and validation period (2 months). Indirectly, method
linearity was also studied during MEff estimation over four con-
centrations (see Section 2.3.1) for FS  LCAS, FS  MCAS and FS  IMBR.
Linearity was observed (R2 ≥ 0.990) for each analyte and sludge
tested (data not shown). Thus, the method showed good specificity
for the analysis of  targeted analytes.
Recoveries of selected drugs for different types of sludge are
given in Table 4. Both absolute and relative method recoveries
were distinguished as  recommended in  the literature [12]. Absolute
MEff values were very different and dependent on the compound
and sludge considered. Absolute MEff ranges were 1.5–33% for IFO
and 2.2–47% for CP. For FS LCAS, FS MCAS and FS IMBR, the agree-
ment between MEff at a  single and four concentrations validate the
“single-point” procedure for each sludge. The absolute recoveries
for IFO and CP were limited for all the samples (<50%) but not crit-
ical for their determination due to  the high sensitivity of  MS/MS
detection. No significant correlation has been found between the
recoveries and sludge features according to pH, VSS and the biolog-
ical process (see Table 1). The very low method efficiency for TPS
sludge impedes the quantitative determination of IFO and CP. Since
VSS was the lowest, other characteristic might be  more relevant
to explain the very low method efficiency. As TPS sludge appeared
partially digested, harsh chemical surroundings of TPS sludge could
have been detrimental for IFO and CP  recovery during the extrac-
tion or purification. Strong matrix effect occurring during analysis
was also possible. Ta
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For the different sludges, relative MEff values were considered
excellent and ranged from 99 to 110% for IFO and from 92  to
105% for CP (see Table 4). Therefore, deuterated standards were
completely suitable for IFO and CP determination in each case.
Moreover, the use of  only one surrogate standard along the entire
protocol provided more accurate results in comparison with ana-
lytical methods using at least two surrogate standards, one for
extraction and one for analysis, as encountered in the literature
[20,21].
The repeatability of  the method was calculated from the
standard deviations given in Table 4  for each sludge. For IFO,  RSD for
absolute and relative MEff were in the range 0.8–15% and 2.4–12%
respectively. For CP, RSD were in  the range 2.4–14% and 1.0–11%
respectively. These values have the significance of  good overall
repeatability (<15%) in  each case. The reproducibility of  the method
has been calculated as the same manner and was below 14% and
considered satisfactory (<15%) for FS LCAS, FS MCAS and FS  IMBR
(data not shown). Therefore, the robustness of the procedure has
been proven.
For IFO and CP, MDL ranged from 3.9 to 74 mg/kgDM and from
2.5 to 51 mg/kgDM respectively (Table 4). With the exception of
TPS sludge, all the MDLs were lower than 10  mg/kgDM display-
ing good overall method sensitivity. The conclusions are  the same
for MQLs lower than 20 mg/kgDM which are the best quantifica-
tion limits reported in the literature for both compound [11]. The
uncommonly low sample and purification sorbent weights applied
in the experimental scheme were not limiting in  the achieve-
ment of low method limits, reaching possible environmental
requirements.
In the overall, our analytical strategy proved good sensitivity,
selectivity and specificity due to  the validation on seven sludge
samples from different origins. However, it is  important to note
that recoveries obtained for spiked samples could overestimate the
efficiency of the method for incurred native analyte [25]. Because of
limitations in diffusion and kinetics of  the sorption process, spiked
analytes will always be less retained than the native ones [27],
To assess the representativeness of freshly spiked compared to
incurred analytes, an additional experiment on PS EMBR sludge has
been carried out. PS EMBR has been continuously contaminated
with anticancer drugs during 80 days. This procedure allows ana-
lytes to penetrate much more into the volume of  the matrix rather
than on the surface. Sludge was sampled on days 10, 30  and 60
during campaign, which corresponds respectively to 0.5, 1.5 and
3 times the sludge age. Each sample was freeze-dried and split
equally in  two. The second aliquot received an additional spiking
of 10 mL  of  MIX Standards. All  the samples were then submitted to
the whole analytical procedure. The measured concentration of  the
freshly spiked sample was corrected by  subtracting the amount of
the  spike to assess the native concentration. The corrected value
was compared to the concentration measured in  the sample with-
out additional spike. No significant differences were measured for
IFO (RSD < 4%) and CP (RSD < 3%). It appears that the proposed ana-
lytical method is not  specific to freshly spiked samples and can be
applied to aged samples. This could be  attributed to  the numer-
ous extraction cycles in  PLE, allowing the exhaustion of the matrix
from easily accessible compartments (spiked) to less accessible
ones (incurred). The sorptive interactions of  IFO and CP  in  freshly
spiked and aged samples could also be comparable.
Fig. 4. (a) Mean recoveries ± standard deviation for IFO in FS MCAS sludge (up) and FS IMBR sludge (down) for the different steps of  the analytical procedure (n =  3). (b)
Mean recoveries ± standard deviation for CP in FS MCAS sludge (up) and FS IMBR sludge (down) for the different steps of the analytical procedure (n = 3). The recoveries
were determined according to  Eq. (4).
3.4. Which analytical step is the most limiting?
As sludge matrix components can strongly influence the effi-
ciency of the sample treatment stage, the objective here was to
determine whether the limited absolute recoveries were linked to
a  same analytical stage or if they  were related to different stages
depending on the sludge nature. To do so, two types of  sludge with
different organic content (i.e. VSS) have been selected and spiked at
different analytical steps described in Section 2.3.2. FS MCAS was
selected for its high organic content (91%) and FS IMBR for its rela-
tively low organic one (75%). TPS sludge (71%) was rejected due to
the  analytical challenge previously described.
The profiles obtained for IFO and CP are displayed in  Fig. 4a  and
b respectively. The absolute recoveries displayed the true efficiency
of the spiking stages. Even if recoveries related to the analysis are
comparable or somewhat higher than those related to the whole
method, the quantification of  IFO and CP is  deeply disturbed by the
matrix effect (ME) in each sample, possibly due to the use of semi-
organic solvent during PLE.  For IFO,  recoveries associated with the
couple “Whole method; Analysis” are 14%; 45% for FS MCAS and
26%; 25% for FS IMBR. For CP, recoveries are 22%; 51% and 38%; 51%.
The use of (semi-) organic solvent during PLE could be responsible
for the extraction of  many interfering compounds as suggested in
the literature [10,15,24] thus decreasing clean-up efficiency and
resulting in relatively high ME.
The efficiency of  each analytical step from the pretreatment
until the analysis has been calculated following Eq. (6)  given in
Section 2.3.2. The results are displayed in  Fig. 5.  Only absolute
recoveries were used for calculation.
Fig. 5. Recovery profiles for IFO (up) and CP (down) in two types of  sludge. The
recoveries  were determined according to Eq. (6).
The profiles are very different between sludges but not between
analytes. For a given sludge sample, it suggests that IFO and CP are
submitted to the same or close processes during each stage. The
high variability observed for some analytical steps is fully explained
by the addition of variances implied by  Eq.  (6) but not critical for
trend explanation.
Pretreatment stage did not imply any  significant losses for IFO
and CP in  each case. Freeze-drying is  often required because wet
samples can prevent from efficient PLE [15]. Grinding ensures
shorter diffusion path-lengths during extraction and enhances sol-
vent penetration [15]. Both  steps can be responsible for losses
but are usually neglected during method development. From our
result it is  demonstrated that non-volatile analytes, which is  the
case of  pharmaceuticals, are not  sensitive to freeze-drying and
grinding. Therefore, the use of spiked freeze-dried samples during
method validation was effectively sufficient. The extractive step led
to satisfactory recoveries between 78 and 105% in  each case. For
sludge samples, the versatility of the optimized PLE method has
been demonstrated. The purification stage efficiency was strongly
dependent on the sludge nature. For both analytes, higher losses
were observed for FS  MCAS sludge. It could be explained by
the nature of  interfering compounds present in the PLE extract,
which may have competed for binding sites and lowering the
clean-up efficiency. It is also important to  note that evaporative
steps along the procedure were not responsible for any analyte
loss.
In the overall, the analysis was the most limiting factor in the
quantification. CP suffered from ME up  to  49% for both sludges
while IFO suffered from ME of  55  and 75% for FS MCAS and
FS IMBR sludges respectively. Additionally, it appeared that sludge
organicity according to VSS measurement was not sufficient to
explain ME as  no correlation between VSS, analytes and ME was
found. Even if VSS is an easy-to-handle and quick measurement, it
seems that the characterization of  the sludge matter and related
extract could be  more relevant in the understanding of  ME ori-
gins.
3.5. Application to environmental samples
Optimized method was applied to the biosolid samples
described in  Table 1.  Measured mean concentrations are given in
Table 5.
Except  for FS  LCAS, one or two  of the targeted drugs were
detected or  quantified in our samples thus confirming the occur-
rence of anticancer drugs in solid part of  sludge. Concentrations in
solid phase for IFO ranged from 11.4 to  42.5 mg/kgDM while CP  was
quantified only in FS MCAS at a concentration of  12.6 mg/kgDM.
This concentration is of the same order of  magnitude than one
reported in the literature for excess sludge [14]. From our  data,
contaminated sludges are mostly those of  WWTPs treating each
day large amounts of  wastewater. It could be thought that the
Table 5
Anticancer  drugs concentrations in collected biosolid samples.
Sludge Pharmaceuticalsa (mg/kgDM)
IFO CP
FS VLCAS  11.4 ± 2.1 <MQL
FS  LCAS <MDL <MDL
FS  MCAS 41 ± 23 12.6 ± 4.9
FS  IMBR 42.5 ± 14.6 <MQL
PS  EMBR <MQL <MDL
PS  IMBR <MQL <MQL
TPS <MQL  <MQL
MDL: method detection limit; MQL: method quantification limit.
a n  = 2,  medium concentration ± standard deviation.
contamination is much more related to  the treated person equiv-
alent number than the sludge physico-chemical nature. The
quantification of IFO in  FS IMBR could be attributed to a possible
accumulation as sludge age is  long (100 days) and biodegradation
is not expected [28–32]. In the overall, very low levels of anti-
cancer drugs were determined in  our solid samples originated
from different WWTPs. This is  in  good agreement with levels of
concentration found or predicted in the literature [6,11,30]. It
could be explained by the relatively low consumption and the
possible low sorption affinity for sludge due to  high  polarity of
IFO and CP. However, low concentrations in sludge may not have
the significance of  low toxicity for microorganisms and more.
Some other field results are requested to confirm or not these first
conclusions.
4. Conclusion
In  this paper, an original analytical method was proposed to
recover anticancer drugs from solid part of  sludge. The experi-
mental set-up consists of extraction from the solid matrix using
PLE, clean-up by selective SPE and analysis by UHPLC–MS/MS.
Some efforts focused on the extraction efficiency, the method vali-
dation and the analytical limitation. The use  of an  experimental
design to optimize the extraction revealed the concomitant effect
of some parameters during extraction, which helped to under-
stand the true functioning of  PLE. The validation of  the method
was applied to seven different sludge samples. Method validation
requirements implying linearity, repeatability, and reproducibil-
ity were fulfilled. The analytical performances were very different
between sludge samples with method efficiencies and MDLs span-
ning more than one order of  magnitude. Thus, method validation
should be systematically applied for each new  sample and could be
of great interest for monitoring programs. Matrix effect occurring
during analysis was demonstrated as the most limiting factor for
the quantification of  each analyte. However, the use of deuterated
standards spiked at the very beginning was efficient to overcome
analytical troubles regardless of  the matrix composition. Vari-
ous sludge samples were analyzed, confirming the environmental
occurrence of anticancer drugs in  sludge. Up to now, the pro-
posed method is only the third analytical procedure available in
the literature for the extraction of anticancer drugs from envi-
ronmental solid samples, each of  them dealing with sludges. The
developed method is also the most sensitive (up to  low mg/kgDM),
detailed and versatile. The need of analytical methods and environ-
mental data about anticancer drugs is  still of  concern to  establish
their occurrence in the water cycle at national and international
scales.
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